Elevated serum levels of adiponectin in children, adolescents and young adults with type 1 diabetes and the impact of age, gender, body mass index and metabolic control: a longitudinal study.

PubWeight™: 0.94‹?› | Rank: Top 15%

🔗 View Article (PMID 17893263)

Published in Eur J Endocrinol on October 01, 2007

Authors

Angela Galler1, Götz Gelbrich, Jürgen Kratzsch, Nicole Noack, Thomas Kapellen, Wieland Kiess

Author Affiliations

1: University Hospital for Children and Adolescents, University of Leipzig, Oststr. 21-25, D-04317 Leipzig, Germany. angela.galler@medizin.uni-leipzig.de

Articles citing this

A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet (2009) 2.09

Serum leptin, adiponectin and tumor necrosis factor-α in hyperlipidemic rats with/without concomitant diabetes mellitus. Mol Med (2010) 0.89

The development of microalbuminuria is associated with raised longitudinal adiponectin levels in female but not male adolescent patients with type 1 diabetes. Diabetologia (2008) 0.84

Adiponectin and arterial stiffness in youth with type 1 diabetes: the SEARCH for diabetes in youth study. J Pediatr Endocrinol Metab (2012) 0.82

Serum adiponectin and hsCRP levels and non-invasive radiological methods in the early diagnosis of cardiovascular system complications in children and adolescents with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol (2013) 0.81

Adiponectin is a Good Marker for Metabolic State among Type 1 Diabetes Mellitus Patients. Iran J Pediatr (2013) 0.80

CTX Correlation to Disease Duration and Adiponectin in Egyptian Children with T1DM. J Med Biochem (2015) 0.75

Longitudinal Analysis of Adiponectin through 20-Year Type 1 Diabetes Duration. J Diabetes Res (2015) 0.75

Study of Adiponectin Level in Diabetic Adolescent Girls in Relation to Glycemic Control and Complication of Diabetes. Open Access Maced J Med Sci (2015) 0.75

Effect of Rosiglitazone and Insulin Combination Therapy on Inflammation Parameters and Adipocytokine Levels in Patients with Type 1 DM. J Diabetes Res (2015) 0.75

Articles by these authors

Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet (2007) 13.62

Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet (2009) 6.39

Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. JAMA (2013) 5.41

Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet (2012) 4.73

Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab (2007) 4.16

Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature (2012) 3.41

IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med (2003) 3.29

CEP152 is a genome maintenance protein disrupted in Seckel syndrome. Nat Genet (2010) 3.25

Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat Genet (2008) 3.24

Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german study groups. PLoS Genet (2010) 3.21

Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J Am Coll Cardiol (2011) 3.13

Nampt: linking NAD biology, metabolism and cancer. Trends Endocrinol Metab (2008) 2.47

Age-specific stabilization in obesity prevalence in German children: a cross-sectional study from 1999 to 2008. Int J Pediatr Obes (2010) 2.47

Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics (2004) 2.10

Incidence rates and predictors of major and minor depression in patients with heart failure. Int J Cardiol (2012) 2.05

Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays. Diabetes Care (2007) 2.04

Serum levels of the adipokine progranulin depend on renal function. Diabetes Care (2012) 2.03

GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. N Engl J Med (2012) 2.01

Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes (2007) 1.96

Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab (2004) 1.92

New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism. Nat Genet (2012) 1.90

Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come. Best Pract Res Clin Endocrinol Metab (2005) 1.87

Serum levels of adipokine retinol-binding protein-4 in relation to renal function. Diabetes Care (2007) 1.85

Exercise training attenuates MuRF-1 expression in the skeletal muscle of patients with chronic heart failure independent of age: the randomized Leipzig Exercise Intervention in Chronic Heart Failure and Aging catabolism study. Circulation (2012) 1.80

Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol (2006) 1.76

ENPP1 variants and haplotypes predispose to early onset obesity and impaired glucose and insulin metabolism in German obese children. J Clin Endocrinol Metab (2006) 1.71

Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure. Eur J Heart Fail (2011) 1.70

Intima media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism (2006) 1.63

Effect of increased exercise in school children on physical fitness and endothelial progenitor cells: a prospective randomized trial. Circulation (2009) 1.61

Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction--results of the Aldo-DHF trial. Int J Cardiol (2013) 1.56

Technical evaluation of the first fully automated assay for the detection of TSH receptor autoantibodies. Clin Chim Acta (2008) 1.56

Impact of weight status on the onset and parameters of puberty: analysis of three representative cohorts from central Europe. J Pediatr Endocrinol Metab (2008) 1.56

Comparison of adrenal function tests in children--the glucagon stimulation test allows the simultaneous assessment of adrenal function and growth hormone response in children. J Pediatr Endocrinol Metab (2005) 1.55

Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial. Clin Res Cardiol (2008) 1.53

Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction. Clin Endocrinol (Oxf) (2014) 1.49

Long-acting insulin analogs and the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes: a prospective study of 10,682 patients from 271 institutions. Diabetes Care (2010) 1.48

Growth in children and adolescents with type 1 diabetes. J Pediatr (2012) 1.47

Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab (2006) 1.47

Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm Res (2003) 1.47

Self-rated health predicts adverse events during β-blocker treatment: the CIBIS-ELD randomised trial analysis. Int J Cardiol (2011) 1.44

Serum levels of the adipokine FGF21 depend on renal function. Diabetes Care (2008) 1.42

Assay-dependent variability of serum insulin levels during oral glucose tolerance test: influence on reference intervals for insulin and on cut-off values for insulin sensitivity indices. Clin Chem Lab Med (2008) 1.42

Elevated sex steroid hormones in great saphenous veins in men. J Vasc Surg (2010) 1.41

Management of diabetes mellitus in infants. Nat Rev Endocrinol (2011) 1.40

Effect of terminated fetal circulation on maternal angiogenic factors in severe early preeclampsia. Hypertens Pregnancy (2012) 1.39

Changes in pediatric diabetes care throughout a 30-yr period at one institution for pediatric diabetology in Germany. Pediatr Diabetes (2002) 1.39

A prismatic case: A 31-year old man who did not miss his pituitary. Hormones (Athens) (2008) 1.38

Antiemetic medications in children with presumed infectious gastroenteritis--pharmacoepidemiology in Europe and Northern America. J Pediatr (2008) 1.35

Basal and feeding-evoked dopamine release in the rat nucleus accumbens is depressed by leptin. Eur J Pharmacol (2003) 1.32

Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS One (2010) 1.25

Prevention of postoperative nausea and vomiting by metoclopramide combined with dexamethasone: randomised double blind multicentre trial. BMJ (2006) 1.22

Phenotypic differences in behavior, physiology and neurochemistry between rats selected for tameness and for defensive aggression towards humans. Horm Behav (2007) 1.19

Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab (2007) 1.19

Dysfunction of autonomic nervous system in childhood obesity: a cross-sectional study. PLoS One (2013) 1.18

Obesity-Related Differences between Women and Men in Brain Structure and Goal-Directed Behavior. Front Hum Neurosci (2011) 1.17

Genetic architecture of tameness in a rat model of animal domestication. Genetics (2009) 1.15

Pregnancy and birth cohort resources in europe: a large opportunity for aetiological child health research. Paediatr Perinat Epidemiol (2013) 1.15

Effects of regular physical activity on control of glycemia in pediatric patients with type 1 diabetes mellitus. Arch Pediatr Adolesc Med (2006) 1.14

Effects of obesity on human sexual development. Nat Rev Endocrinol (2012) 1.13

Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF). Eur J Heart Fail (2007) 1.12

Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes. Front Biosci (Landmark Ed) (2009) 1.12

Adipose tissue expression and genetic variants of the bone morphogenetic protein receptor 1A gene (BMPR1A) are associated with human obesity. Diabetes (2009) 1.11

Validation of the phenylalanine/tyrosine ratio determined by tandem mass spectrometry: sensitive newborn screening for phenylketonuria. Clin Chem Lab Med (2002) 1.11

Molecular characteristics of serum visfatin and differential detection by immunoassays. J Clin Endocrinol Metab (2007) 1.11

Body mass index, waist circumference, and waist-to-height ratio as predictors of cardiometabolic risk in childhood obesity depending on pubertal development. J Clin Endocrinol Metab (2013) 1.10

Are HIV patients undertreated? Cardiovascular risk factors in HIV: results of the HIV-HEART study. Eur J Prev Cardiol (2011) 1.09

Incidence of childhood diabetes in children aged less than 15 years and its clinical and metabolic characteristics at the time of diagnosis: data from the Childhood Diabetes Registry of Saxony, Germany. Horm Res Paediatr (2010) 1.08

Secular trends in body mass index in German children and adolescents: a cross-sectional data analysis via CrescNet between 1999 and 2006. Metabolism (2008) 1.08

Serum levels of adipocyte fatty acid-binding protein (AFABP) are increased in chronic haemodialysis (CD). Clin Endocrinol (Oxf) (2008) 1.07

Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight. Biochem Biophys Res Commun (2005) 1.06

New predictors of the metabolic syndrome in children--role of adipocytokines. Pediatr Res (2007) 1.06

Adipocytes and adipose tissue. Best Pract Res Clin Endocrinol Metab (2008) 1.06

Dimenhydrinate in children with infectious gastroenteritis: a prospective, RCT. Pediatrics (2009) 1.05

Effects of exercise training on insulin-like growth factor-I expression in the skeletal muscle of non-cachectic patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil (2005) 1.05

Circulating IGF-I levels in childhood are related to both current body composition and early postnatal growth rate. J Clin Endocrinol Metab (2002) 1.05

TCF7L2 gene polymorphisms confer an increased risk for early impairment of glucose metabolism and increased height in obese children. J Clin Endocrinol Metab (2007) 1.04

Insulin-like growth factor I, growth hormone and insulin in white adipose tissue. Best Pract Res Clin Endocrinol Metab (2005) 1.04

Muscular levels of proinflammatory cytokines correlate with a reduced expression of insulinlike growth factor-I in chronic heart failure. Basic Res Cardiol (2003) 1.04

Association of plasma resistin levels with coronary heart disease in women. Obes Res (2005) 1.04

Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA. Diabetes Care (2003) 1.03

PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis. J Clin Endocrinol Metab (2004) 1.03

Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives. Cancer Med (2013) 1.02

Chemerin as a mediator between obesity and vascular inflammation in children. J Clin Endocrinol Metab (2012) 1.01